Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense⢠reagents, a powerful technology designed to advance internalization studies in drug discovery. pH...